PrEP at a Syringe Services Program

NCT04782180 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Hiv
Substance Use Disorders

Interventions

DRUG: Descovy 200Mg 25Mg Tablet
BEHAVIORAL: PrEP

Sponsor

University of Miami

Collaborators

[object Object]